Market Access News | pharmaphorum

News

President Trump will continue Medicare drug pricing negotiation but intends to look for improvements to the scheme according to CMS.

News

ALK-Abello's Acarizax for dust mite allergy should soon be available through the NHS in England, Wales and Northern Ireland, but not in Scotland.

News

Robert F Kennedy Jr's first confirmation hearing was a fractious affair, marked by tough questions about his prior anti-vaccine stance.

News

Novo Nordisk's Ozempic has become the first drug in the GLP-1 class to be cleared to prevent worsening kidney disease in type 2 diabetics.

News

RFK Jr is unfit to lead the Department of Health and Human Services (HHS), according to members of his own family.

News

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment.